Lymphoma Management in North Carolina: Updates for 2023 |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 NCPD/CNE
- 1.00 Participation
- 1.00 CTR Category A
|
Enduring |
|
$0.00 |
Demystifying Molecular-Based Tests in Head and Neck Cancers |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Radiation Oncology in North Carolina: Bladder Cancer Updates for 2020 - SPOC |
|
Enduring |
|
$0.00 |
Occupational Therapy and Cancer Rehabilitation |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Lymphoma Management Updates for 2021 - SPOC |
|
Enduring |
|
$0.00 |
An Introduction to Cancer Registry Operations - SPOC |
|
Enduring |
|
$0.00 |
Genitourinary Oncology Update 2021 SPOC |
|
Enduring |
|
$0.00 |
Caring for Patients with GI Cancers - SPOC |
|
Enduring |
|
$0.00 |
Mantle Cell Lymphoma Management in North Carolina: Updates for 2020 SPOC |
|
Enduring |
|
$0.00 |
The Role of Patient Support Networks in Cancer Outcomes SPOC |
- 1.00 CTR
- 1.00 Participation
|
Enduring |
|
$0.00 |
Cancer Pathology: How Diagnosis Drives Treatment |
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Building Cancer Care Collaboratives for the Seventh Generation - SPOC |
|
Enduring |
|
$0.00 |
Psycho-Social Complications of Receiving a Cancer Diagnosis and Treatment During the Pandemic - SPOC |
|
Enduring |
|
$0.00 |
Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 NCPD/CNE
- 1.00 Participation
|
Enduring |
|
$0.00 |
Common Considerations in Caring for Patients with Cancer |
|
Enduring |
|
$0.00 |